[1]
H. Bojanowski, “Effects of GLP-1 Receptor Agonists on Bone Metabolism and Fracture Risk in Type 2 Diabetes and Obesity: Mechanisms and Clinical Evidence — A Narrative Review”, J Educ Health Sport, vol. 90, p. 70093, Apr. 2026.